Vigabatrin liquid vs powder vs tablets

Short answer: the ready-to-use liquid (Vigafyde, 100 mg/mL) removes the mixing step that every powder dose needs, halves the volume of each dose, and keeps for 90 days once opened. In the one study that compared them directly, caregivers measured the liquid far more accurately than doses mixed from powder. That study was small and funded by the liquid's maker, and the liquid is labeled only for infantile spasms in babies 1 month to 2 years old.^1,2

All three forms contain the same medicine. Vigafyde was approved by comparing its composition with vigabatrin powder solution, so its benefits and risks, including the vision-loss warning, are the same.¹ The differences are practical, but for a medicine given twice a day to a baby, practical differences add up.

What happens before each dose

Powder sachets. The label tells caregivers to empty each 500 mg packet into a clean cup, dissolve it in 10 mL of cold or room-temperature water, check that the solution is clear, draw up the prescribed volume, give it right away, and throw away the rest.³ Doses up to 500 mg need one packet and 10 mL of water; doses up to 1,000 mg need two packets and 20 mL; doses up to 1,500 mg need three packets and 30 mL. The same steps apply to Vigadrone and other generic powders.⁶ The Sabril label asks prescribers to confirm that caregivers understand how to mix it and give the right dose.³

That routine happens twice a day, every day. For a 5 kg baby starting treatment, each 125 mg dose uses a whole 500 mg packet, and 7.5 mL of the mixed solution (375 mg) is thrown away each time.³

Ready-to-use liquid. The label says Vigafyde "does not require additional reconstitution or dilution." The dose is drawn straight from the bottle with a calibrated oral syringe.¹

Tablets. Tablets are swallowed. They are used for refractory complex partial seizures from age 2; babies with infantile spasms are dosed with an oral solution.⁴

Dose accuracy: what the evidence shows

The direct comparison

A 2025 study asked 30 people (15 experienced vigabatrin caregivers and 15 people who had never used an oral syringe) to prepare one dose of 1,125 mg from the ready-to-use liquid and one from Sabril powder, using only the written instructions.²

• Ready-to-use liquid
• Mixed powder

Within 10% of the target dose

Ready-to-use liquid

100%

Mixed powder

77%

Within 2% of the target dose

Ready-to-use liquid

70%

Mixed powder

20%

30 people, one 1,125 mg dose of each. Small study funded by the liquid’s maker.

Show as a table

Group	Measure	Value
Within 10% of the target dose	Ready-to-use liquid	100%
Within 10% of the target dose	Mixed powder	77%
Within 2% of the target dose	Ready-to-use liquid	70%
Within 2% of the target dose	Mixed powder	20%

• Ready-to-use liquid: all 30 doses were within 5% of the target. About 70% were within 2%.
• Powder: 23 of 30 doses (77%) were within 10%. Doses ranged from 425 mg to 1,390 mg, that is, from 62% too little to 24% too much. About 20% were within 2%.
• On average the liquid delivered 99% of the intended dose and the powder 90%.
• People measured the volumes of both products equally well. The errors came from mixing the powder.
• Experienced caregivers did no better with the powder (10 of 15 within 10%) than first-time users (13 of 15).

Limits of this study. The authors worked for the company that makes Vigafyde. It was small, each person made a single dose in a test setting, and the target dose (22.5 mL of powder solution) was larger than a typical infant dose. People could not ask questions, which the authors note is not how the label expects caregivers to be taught. No study has compared seizure outcomes between the two forms.²

Why measuring liquid medicine at home is hard in general

Independent research on children's liquid medicines points the same way. In a trial of 2,110 parents, 84% made at least one dosing error and 21% gave more than double the intended dose at least once, even without any mixing step.⁷ Errors were lowest when the syringe size matched the dose: for a 7.5 mL dose, a 10 mL syringe used once worked better than a smaller syringe refilled.⁸ Parents of children with complex medical needs felt confident (81 to 99%), yet only 55% measured two doses correctly.⁹ The American Academy of Pediatrics notes that errors are most common with liquid medicines and complicated schedules, and that children with chronic conditions are affected most.¹⁰

Mixing adds a second chance for error before measuring even starts. In a study of a reconstituted antibiotic, most participants skipped the "shake before use" step, and the doses they measured differed from the intended dose.¹¹ Splitting tablets is also imprecise: across 13 studies, split tablets were acceptably even only 55% of the time.¹² These studies were not about vigabatrin, but they describe the same steps.

Why accuracy matters early in treatment

With infantile spasms, the first weeks count. In a national cohort, babies who responded to vigabatrin did so in a median of 3 days, and experts advise reassessing any baby who has not responded within a week.¹³ Longer delays to effective treatment and failure to stop spasms early are linked to worse development later.^14,15 In vigabatrin's own trial, higher doses stopped spasms more often than low doses.¹⁶ A dose that comes out 10% or 60% short during that window is not a small matter. This link is indirect: no study has tied the choice of formulation to a baby's outcome.

Doses that come out too high matter too. Brain MRI changes in infants have been linked to higher peak doses in some studies, though not in all.^17,18

Volume per dose

The liquid is twice as concentrated as mixed powder, so every dose is half the volume.¹

Ready-to-use liquid, 100 mg/mL

7.5 mL

Drawn straight from the bottle. Fits in one 10 mL oral syringe.

Mixed powder, 50 mg/mL

15 mL

Two packets dissolved in 20 mL of water; 15 mL is given and 5 mL is thrown away. More than one 10 mL syringe-full.

Scale marks every 1 mL, 0–20 mL. Volumes from the FDA dosing tables for each product. Twice daily.

• Ready-to-use liquid, 100 mg/mL
• Mixed powder, 50 mg/mL

3 kg

Liquid

2.25 mL

Powder

4.5 mL

5 kg

Liquid

3.75 mL

Powder

7.5 mL

10 kg

Liquid

7.5 mL

Powder

15 mL

Show as a table

Group	Measure	Value
3 kg	Liquid	2.25 mL
3 kg	Powder	4.5 mL
5 kg	Liquid	3.75 mL
5 kg	Powder	7.5 mL
10 kg	Liquid	7.5 mL
10 kg	Powder	15 mL

Smaller volumes are easier to give to a baby, but very small volumes are harder to measure: syringes become less accurate below about 0.1 mL.¹⁹ Ask the pharmacy for a syringe that matches your baby's dose.

Storage and waste

An opened bottle of Vigafyde is kept at 2 to 30 °C and thrown away 90 days after opening.¹ Mixed powder, by label, is made fresh for every dose and the remainder discarded.³ A 2025 lab study by a generic powder maker found that mixed powder stayed stable for 48 hours in the fridge in water, juice, milk or formula, but the approved labels have not changed.²⁰

Handling and exposure

Vigabatrin is on the federal NIOSH list of hazardous drugs because of possible harm to pregnancy and development.²¹ NIOSH guidance for healthcare workers says that crushing tablets or opening capsules should be avoided and that "liquid formulations should be used whenever possible."⁵ That guidance is written for workplaces, not homes, and NIOSH still advises gloves for staff giving any oral liquid. At home, the practical point is simple: the liquid involves no powder to pour or tablets to crush. See safe handling.

Trade-offs and limits

• Switching needs care. The same number of mL of the liquid gives twice the dose of mixed powder. The label warns prescribers, pharmacists and caregivers to check the volume when switching.¹
• Label scope. The liquid is labeled only for infantile spasms in babies 1 month to 2 years old. It is not approved for refractory complex partial seizures or for adults.¹
• Same medicine, same risks. No formulation changes the risk of vision loss, the REMS requirements, or the MRI findings in infants.
• The evidence is thin. One small, manufacturer-funded study compares the forms directly. The broader research on dosing errors supports the same conclusion but was not about vigabatrin.
• Cost and coverage vary. Insurance coverage differs between products; see cost.

Who the ready-to-use liquid is for

The liquid is designed for babies with infantile spasms between 1 month and 2 years old, the group in which doses change with weight, volumes are small, and the first weeks of treatment matter most.¹ Older children and adults with refractory complex partial seizures use tablets or powder. If your baby is on powder now, ask the prescriber whether the ready-to-use liquid is an option. Use the dose calculator to see label volumes for each form.